The expression of upstream survival signals (GSK-3β, β-catenin, c-myc and cyclin D1) in human colon adenocarcinoma Caco-2 cells was evaluated after epirubicin treatment with or without galectin-3 knockdown. This evidence concerns the gene CCND1 and colon adenocarcinoma.